Clinical Randomisation of an Anti-fibrinolytic in Symptomatic Mild Head Injury in Older Adults
Status:
Recruiting
Trial end date:
2025-03-31
Target enrollment:
Participant gender:
Summary
Tranexamic acid (TXA) reduces head injury deaths. The CRASH-4 trial aims to assess the
effects of early intramuscular TXA on intracranial haemorrhage, disability, death, and
dementia in older adults with symptomatic mild head injury